Top Interviews from 2023 MDA: Expert Insights on Neuromuscular Diseases


A group of experts in the care of patients with neuromuscular diseases—Douglas Sproule, MD, MSc; David Brumbaugh, MD; Sharon Hesterlee, PhD; Lauren Treat, MD; Donovan Lott, PT, PhD, CSCS—shared their perspectives on hot topics of treatment and management from the 2023 MDA conference.

In recent months, the NeurologyLive® staff has spoken to a variety of experts in the clinical care and management of patients with neuromuscular diseases, including those with amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), cerebral palsy, spinal muscular atrophy (SMA), and rare diseases.

To recap the recent 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, March 19-22, in Dallas, Texas, NeurologyLive® compiled a number of interviews with experts from the conference to offer an overview of the state of care and discussions on the hottest topics in neuromuscular diseases. Those featured include:

  • Douglas Sproule, MD, MSc, chief medical officer at ML Bio Solutions
  • David Brumbaugh, MD, associate professor of pediatrics at the University of Colorado School of Medicine
  • Sharon Hesterlee, PhD, executive vice president and chief research officer of MDA
  • Lauren Treat, MD, child neurologist at the University of Colorado School of Medicine
  • Donovan Lott, PT, PhD, CSCS, research associate professor in the department of physical therapy at the University of Florida

Click here for more coverage of MDA 2023.

Click through the slides below to check out each expert interview:


Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.